Abstract A 25-year-old female presented to a university neurology clinic with a 1-month history of progressive ataxia, downbeat nystagmus and spastic tetraparesis. Personal history revealed polyarthralgias and weight loss. Family history was negative. Following thorough history, laboratory, neurophysiological and MRI investigations, a diagnosis of cerebellar ataxia due to coeliac disease was done. The patient was treated with strict gluten-free diet and intravenous administration of immunoglobulins. Although there are many controversies about neurological manifestations of coeliac disease, this case pointed to strong association between these two disorders. The findings of elevated protein content in the cerebrospinal fluid with positive oligoclonal bands suggested an immune-mediated process, further supported by positive anti-endomysium antibodies and anti-transglutaminase antibodies in the cerebrospinal fluid.
Introduction
We describe a case of ataxia, spastic tetraparesis and cognitive decline due to coeliac disease.
Case report
A 25-year-old woman was referred to our department because of ataxia. Her personal history revealed polyarthralgia 3 years before because of which she was evaluated at internal medicine department; immunological tests were negative and she was diagnosed with reactive arthritis. Therapy with low-dose corticosteroids resulted in complete recovery. Following that, she developed postural tremor in her upper extremities, examined by a local neurologist and prescribed propranolol for presumed essential tremor. Two years later, she was hospitalised at Department of Internal Medicine for recurrent polyarthralgia. Ureaplasma urealyticum was isolated from cervical smear; therapy with doxycycline led to full recovery.
One month before admission to our department, she was hospitalised again at local Department of Internal Medicine for 15 kg weight loss and polyarthralgia especially affecting her hands. At the same time, she started developing walking difficulties, oscillopsia and occasional diplopia.
Her complaints were initially thought to be consequential to depression; therefore, she was transferred to Department of Psychiatry, where therapy with sertraline and sulpiride was initiated. As she did not recover, a neurologist was consulted and the patient was transferred to our department.
On admission, neurological examination revealed fully alert patient, her speech showed scanning dysarthria. She had downbeat nystagmus in all directions of gaze, more pronounced in full lateral gaze (Video 1, Electronic Supplementary Material), spastic tetraparesis, muscle strength was 3/5 on the right hand, 4/5 on the right hand, 2/5 on the right leg and 3/5 on the left leg, decreased reflexes (1?) and positive Babinski bilaterally. She had severe dysmetria and intentional tremor on all four extremities, and she could neither walk nor sit on her own. Cognitive examination showed Mini-mental state examination 29/30, ACE-R 94/100, mainly due to the visuospatial component of the test, which could be explained by motor and coordination problems. Family history for ataxia was negative.
Laboratory results showed elevated erythrocyte sedimentation rate (40 mm/h), and normal complete blood count, electrolytes, liver and kidney function tests, and C-reactive protein. 3 , elevated proteins 0.93 g/L (n.v.\0.37 g/L), and positive oligoclonal bands. Electroneurography showed signs of mild sensory polyneuropathy. Due to weight loss and polyarthralgias, we performed upper endoscopy with distal duodenal biopsy. Histopathology showed villous atrophy, crypt hyperplasia, increased mononuclear infiltration of the lamina propria and an increased number of intraepithelial lymphocytes (25 per 100 epithelial cells). PAS staining was negative. We then performed tests for serum IgA anti-endomysium antibodies (EMA) and serum IgA anti-transglutaminase antibodies (tTG), which were negative and positive (68 RU/mL), respectively, with normal levels of serum IgA. We also performed additional CSF analysis for these antibodies and both were positive (EMA, positive titre and tTG, 84 RU/ mL). HLA genotyping revealed the HLA DQ 2 allele.
The diagnosis of cerebellar ataxia due to coeliac disease (CD) was done. The patient was treated with 50 g of intravenous administration of immunoglobulins with modest recovery and she was transferred to stationary rehabilitation on strict gluten-free diet. On follow-up at 3 and 6 months, she was stable, with modest improvement of motor strength but persistent ataxia. Repeat tests for EMA and tTG antibodies were negative, and gastrodudenoscopy was normal, confirming the patient was adherent to the diet.
Discussion
In this case, the patient presented with severe cerebellar syndrome. The most prominent neurological feature was downbeat nystagmus (DBN) (Video 1, Electronic Supplementary Material). DBN is often the result of a bilateral lesion of the flocculus or paraflocculus, or caused by a lesion at the bottom of the 4th ventricle [1, 2] . It is estimated that DBN is either a drug-induced dysfunction or associated with structural lesion (25% of cases with craniocervical junction anomalies, e.g., Chiari malformation and 20% with cerebellar degeneration); however, the aetiology remains unknown in about 50% of cases [2] . Our patient also had signs of pyramidal tract involvement and brain MRI was completely normal indicating a more diffuse pathological process. Another important fact was the history of polyarthralgia and weight loss, which indicated systemic illness. That is why upper endoscopy with distal duodenal biopsy was performed to yield histopathological findings consistent with CD. These findings were confirmed by positive serum IgA tTG. The final diagnosis was based on positive EMA and tTG in the CSF.
Coeliac diseases are a chronic immune-mediated disorder that primarily affects the gastrointestinal tract. Many patients, especially adults, may be asymptomatic or have only extra intestinal symptoms at the onset, without any of the classical coeliac symptoms [3] . The best described neurological complications of CD are ataxia, peripheral neuropathy and epilepsy, and more controversial ones include myopathy, autonomic neuropathy, white matter lesions, headache, cognitive impairment, multiple system atrophy, dystonia and childhood stroke [4] . There is the strongest evidence for the association between ataxia and CD. The only pathological studies performed in patients with CD and ataxia showed that there was lymphocytic infiltration of the cerebellum, damage to the posterior columns of the spinal cord and sparse infiltration of the peripheral nerves [5] . These findings support the hypothesis that neurological manifestations of CD are immunemediated. Evidence suggests that there might be antibody cross-reactivity between antigenic epitopes on Purkinje cells and gluten proteins. Serum from patients with gluten ataxia and from patients with CD without neurological symptoms showed cross-reactivity with epitopes on Purkinje cells of both human and rat cerebellum [6] . Other studies have shown no association between CD and ataxia [7] . However, CD was found in 36% of patients with idiopathic cerebellar ataxia with extracerebellar presentation (autonomic instability, Parkinsonism, or pyramidal dysfunction in varying combinations) [8] . Similarly, our patient had cerebellar symptomatology with pyramidal tract involvement. All of these studies had many limitations [4] , and although there are no prospective studies, evidence weighs in support of causal relationship between ataxia and CD. However, one prospective study indicated that neuropathy, usually subclinical, may accompany CD, and antibody titres did not seem to correlate with neurological symptoms and/or signs or diet [9] . It is also worthy mentioning that subclinical neurological abnormalities associated with CD are found in 11% of children with CD, which mean that these patients should be carefully monitored for neurological complications [10] . Some patients with ataxia who have normal duodenal biopsy and positive antigliadin antibodies may also have HLA haplotypes that are associated with CD [11] , indicating a wide spectrum of clinical manifestations of gluten sensitivity and suggesting the possibility that such patients might develop CD at some point of time [12] .
Only few studies investigated the role of antigliadin, tTg and EMA in the CSF. In one study, the authors analysed the presence of IgA and IgG tTG in 129 samples and found positive titres in 27 and 63 CSF samples, respectively. Unfortunately, there are no clinical data on the patients and on the possible presence of CD in these patients [13] . Another study showed negative CSF antigliadin antibodies and EMA in all study patients with ataxia and CD [11] . The role of tTG and EMA CSF antibodies remains to be elucidated.
Differential diagnosis of sporadic, adult-onset ataxias is broad, especially if neurological findings such as pyramidal or sensory tract involvement are present. Autosomal dominant spinocerebellar ataxias may have diverse-associated neurological features including retinopathy, optic atrophy, extrapyramidal or pyramidal signs, peripheral neuropathy, cognitive impairment, or epilepsy, but in most instances family history is positive, although it may not be clearly visible [14] . Autosomal recessive ataxias are generally associated with peripheral sensorimotor neuropathy, most notably with loss of proprioception and vibration sense, and tend to have involvement outside the nervous system [15] . Although most of recessive ataxias have their onset in childhood, late-onset Freidreich ataxia (FA) ([25 years of age) can present with gait and limb ataxia, dysarthria, loss of vibration sense, abnormal eye movements, limb spasticity and retained reflexes [16] . The patient had presented all these features, but genetic tests for FA and for most frequent dominant ataxias were negative.
When the symptoms are not restricted to the central nervous system, systemic diseases should be considered. In this case study, associated polyarthralgia and weight loss suggested neuro-Whipple's disease. Neuro-Whipple's disease can present with gastrointestinal or rheumatological features, or as a primary central nervous system infection, but neurological manifestations do not distinguish primary from secondary form of the disease, emphasising that brain MRI can be normal and any abnormalities are non-specific [17] . The diagnosis is done by duodenal, lymph node or brain biopsy, polymerase chain reaction (PCR) analysis and CSF analysis; MRI is crucial during follow-up, and treatment consists of prolonged antibiotic therapy with drugs that are able to cross the blood-brain barrier [18] . In our patient, Whipple's disease was excluded by negative duodenal biopsy.
Ataxia associated with CD can have almost identical presentation as neuro-Whipple's disease, as discussed in more detail in previous chapter. Hypothyroidism can also present with ataxia; however, these patients usually do not have weight loss. Patients with neurological manifestations and positive anti-TPO antibodies are often diagnosed with Hashimoto encephalopathy, but this disease almost never presents with ataxia [19] . On the other hand, patients with CD often have associated autoimmune disorders, the pathogenesis of which is not known, but these conditions share similar HLA haplotypes, so screening of high risk patients for CD, such as those with autoimmune diseases, is a reasonable strategy given the increased prevalence [20] .
Currently, the only treatment for CD is adherence to strict gluten-free diet [21] . However, neurological manifestations, especially neuropathy and ataxia, seem to be resistant to strict gluten-free diet [11] . Recently, there is evidence for the effect of intravenous administration of immunoglobulins in ataxia and peripheral neuropathy associated with CD [22, 23] . Maintenance IVIg treatment may be needed for long-term management of these disorders [22, 23] . The fact that neurological symptoms improve or are even reversible in response to IVIg suggests an immune-mediated process that may be occurring independently of gluten exposure [23] . The effect of IVIG treatment in our patient was modest; there was significant improvement of nystagmus and muscle strength, but only modest in ataxia. Although we are in need of prospective randomized trials in the management of neurological complications of CD, it seems reasonable to put these patients on strict gluten-free diet and treat them with either corticosteroids or IVIG until clinical improvement.
Conclusion
The patient discussed in this case study presented with cerebellar syndrome and pyramidal tract involvement.
The differential diagnosis of adult-onset cerebellar ataxia with normal brain MRI findings is very wide and includes genetic, inflammatory, endocrinological, paraneoplastic and systemic illnesses. After thorough investigation, the diagnosis of ataxia due to CD was done based on duodenal biopsy and positive antibodies in both serum and CSF. Other causes were excluded by appropriate tests.
Although there are many controversies about neurological manifestations of CD, this case demonstrated strong association between these two disorders. The findings of elevated protein content in the CSF with positive oligoclonal bands suggested an immune-mediated process, further supported by positive tTG and EMA in the CSF.
